[5-FU+CDDP(FP) +cetuximab in recurrence/metastasis head and neck cancer]

Nihon Rinsho. 2015 Feb:73 Suppl 2:562-6.
[Article in Japanese]
No abstract available

MeSH terms

  • Antibodies, Monoclonal, Humanized / administration & dosage
  • Antibodies, Monoclonal, Humanized / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Cetuximab
  • Cisplatin / administration & dosage
  • Cisplatin / adverse effects
  • Fluorouracil / administration & dosage
  • Fluorouracil / adverse effects
  • Head and Neck Neoplasms / drug therapy*
  • Humans
  • Neoplasm Metastasis
  • Recurrence

Substances

  • Antibodies, Monoclonal, Humanized
  • Cetuximab
  • Cisplatin
  • Fluorouracil